PT  - JOURNAL ARTICLE
AU  - Bryan Ceronie
AU  - Thomas Hart
AU  - Daniel Belete
AU  - Lucille Ramani
AU  - Anish Bahra
TI  - Isolated headache is not a reliable indicator for brain cancer: the 2-week wait pathway for suspected CNS malignancies
AID  - 10.7861/clinmed.CM-2021-0223
DP  - 2021 Nov 01
TA  - Clinical Medicine
PG  - e648--e655
VI  - 21
IP  - 6
4099  - http://www.rcpjournals.org/content/21/6/e648.short
4100  - http://www.rcpjournals.org/content/21/6/e648.full
SO  - Clin Med2021 Nov 01; 21
AB  - Introduction The UK uses the 2-week-wait (2WW) pathway for rapid access to cancer services. It is unclear whether this is effective for brain cancer.Methods We retrospectively analysed all 2WW referrals for brain cancer between 2009 and 2016 in a district general neurology department. We compared clinical presentations to national guidelines and diagnoses of brain cancer.Results Of the 153 cases analysed, four brain cancers were identified: two glioblastomas and two metastases. Headaches were the most common referral. The end diagnosis was mostly migraine. The highest positive predictive value was for behavioural/personality change (5.3%) and sub-acute neurological deficit (3.2%). There was no significant association between any symptom(s) and brain cancer.Conclusion The 2WW pathway is not effective in the diagnosis of brain cancer. Resources are better directed towards clinical research and treatment trials. Headache remains the most common reason for referral although it is not yet a reliable indicator of brain cancer.